Insider NameBuy/SellCompany NameTickerAmountShares Change
May 15, 2025May 19, 2025Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$46.13$129,717-2.64%
Mar 12, 2025Mar 14, 2025Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$53.3$827,233-13.00%
Mar 10, 2025Mar 12, 2025Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$53.08$4M-42.06%
Feb 19, 2025Feb 21, 2025Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$50.11$147,678-2.76%
Jan 07, 2025Jan 10, 2025Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$44.87$158,871-3.21%
Dec 02, 2024Dec 04, 2024Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$52.37$5M-50.93%
Jan 30, 2024Feb 01, 2024Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$27.25$21,637-1.10%
Jan 08, 2024Jan 10, 2024Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$28.85$97,960-4.50%
Apr 17, 2023Apr 19, 2023Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$51.42$3M-45.10%
Jan 31, 2023Feb 02, 2023Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$45.63$37,050-1.07%
Jan 10, 2023Jan 12, 2023Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$43.58$47,288-1.40%
Jan 09, 2023Jan 11, 2023Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$41.66$34,783-1.07%
Oct 17, 2022Oct 19, 2022Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$55$379,572-10.15%
Sep 20, 2022Sep 22, 2022Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$55$64,680-1.89%
Apr 13, 2022Apr 15, 2022Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$45.17$102,811-3.59%
Apr 05, 2022Apr 07, 2022Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$45$225-0.01%
Feb 10, 2022Feb 11, 2022Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$45.03$807,559-22.69%
Feb 01, 2022Feb 03, 2022Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$40$31,162-1.26%
Jan 07, 2022Jan 11, 2022Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$38.53$34,095-1.41%
Sep 02, 2021Sep 03, 2021Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$45.01$151,375-6.50%
Jul 08, 2021Jul 12, 2021Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$45.19$417,274-16.03%
Feb 01, 2021Feb 02, 2021Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$56.96$44,312-1.58%
Jan 05, 2021Jan 07, 2021Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$62.37$48,150-1.94%
Jul 07, 2020Jul 09, 2020Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$55.12$2M-43.53%
Jul 05, 2019Jul 09, 2019Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$44.74$685,097-34.15%
Jun 28, 2019Jul 02, 2019Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$45$8M-86.02%
Jun 08, 2015Jun 10, 2015Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$55.04$3M-77.69%
Mar 20, 2015Mar 23, 2015Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$68.12$1M-65.59%
Mar 20, 2014Mar 21, 2014Boulding Mark Elliott
EVP
CLO
SellPtc Therapeutics, Inc.PTCT$30.96$311,117-23.77%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.